Discontinued Operations - Additional Information (Details) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Mayne Pharmaceutical
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Incremental accrual	$ 2,000,000		$ 2,000,000
Annoveras | Discontinued Operations
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
General and administrative operating support expense					$ 0
License payment received					140,000,000
Cash received for acquisition of net working capital subject to certain adjustments					12,100,000
Revenue from transaction	$ (833,000)	$ 20,562,000	$ (833,000)	$ 67,413,000
Annoveras | Discontinued Operations | Mayne License
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]
Revenue from transaction					$ 1,000,000